Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Indivior Pharmaceuticals Inc. (NASDAQ : INDV ) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Quote
| Last: | $32.43 |
|---|---|
| Change Percent: | -0.06% |
| Open: | $33 |
| Close: | $32.45 |
| High: | $33.62 |
| Low: | $32.27 |
| Volume: | 354,301 |
| Last Trade Date Time: | 04/15/2026 12:45:13 pm |
Stock Data
| Market Cap: | $4,174,798,177 |
|---|---|
| Float: | 123,522,122 |
| Insiders Ownership: | 1.6% |
| Institutions: | 31 |
| Short Percent: | N/A |
| Industry: | Pharmaceuticals |
| Sector: | Healthcare |
| Website: | http://www.indivior.com |
| Country: | GB |
| City: | North Chesterfield |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Indivior Pharmaceuticals Inc. (NASDAQ: INDV).
